Correlation Between Cyclo Therapeutics and Sunshine Biopharma
Can any of the company-specific risk be diversified away by investing in both Cyclo Therapeutics and Sunshine Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclo Therapeutics and Sunshine Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclo Therapeutics and Sunshine Biopharma Warrant, you can compare the effects of market volatilities on Cyclo Therapeutics and Sunshine Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclo Therapeutics with a short position of Sunshine Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclo Therapeutics and Sunshine Biopharma.
Diversification Opportunities for Cyclo Therapeutics and Sunshine Biopharma
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cyclo and Sunshine is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Cyclo Therapeutics and Sunshine Biopharma Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunshine Biopharma and Cyclo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclo Therapeutics are associated (or correlated) with Sunshine Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunshine Biopharma has no effect on the direction of Cyclo Therapeutics i.e., Cyclo Therapeutics and Sunshine Biopharma go up and down completely randomly.
Pair Corralation between Cyclo Therapeutics and Sunshine Biopharma
Given the investment horizon of 90 days Cyclo Therapeutics is expected to under-perform the Sunshine Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Cyclo Therapeutics is 3.78 times less risky than Sunshine Biopharma. The stock trades about -0.03 of its potential returns per unit of risk. The Sunshine Biopharma Warrant is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest 7.70 in Sunshine Biopharma Warrant on August 28, 2024 and sell it today you would earn a total of 13.30 from holding Sunshine Biopharma Warrant or generate 172.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cyclo Therapeutics vs. Sunshine Biopharma Warrant
Performance |
| Timeline |
| Cyclo Therapeutics |
| Sunshine Biopharma |
Cyclo Therapeutics and Sunshine Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cyclo Therapeutics and Sunshine Biopharma
The main advantage of trading using opposite Cyclo Therapeutics and Sunshine Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclo Therapeutics position performs unexpectedly, Sunshine Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will offset losses from the drop in Sunshine Biopharma's long position.| Cyclo Therapeutics vs. Eliem Therapeutics | Cyclo Therapeutics vs. Scpharmaceuticals | Cyclo Therapeutics vs. Milestone Pharmaceuticals | Cyclo Therapeutics vs. Seres Therapeutics |
| Sunshine Biopharma vs. Sunshine Biopharma | Sunshine Biopharma vs. Thayer Ventures Acquisition | Sunshine Biopharma vs. Biofrontera Warrants | Sunshine Biopharma vs. Neurosense Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |